Issue navigation
Volume 74, Issue 3, March 2019
For debate
Harnessing alternative sources of antimicrobial resistance data to support surveillance in low-resource settings
Journal of Antimicrobial Chemotherapy, Volume 74, Issue 3, March 2019, Pages 541–546, https://doi.org/10.1093/jac/dky487
Original research
A mecC allotype, mecC3, in the CoNS Staphylococcus caeli, encoded within a variant SCCmecC
Journal of Antimicrobial Chemotherapy, Volume 74, Issue 3, March 2019, Pages 547–552, https://doi.org/10.1093/jac/dky502
The roles of HicBA and a novel toxin–antitoxin-like system, TsxAB, in the stability of IncX4 resistance plasmids in Escherichia coli
Journal of Antimicrobial Chemotherapy, Volume 74, Issue 3, March 2019, Pages 553–556, https://doi.org/10.1093/jac/dky491
ST131 fimH22 Escherichia coli isolate with a blaCMY-2/IncI1/ST12 plasmid obtained from a patient with bloodstream infection: highly similar to E. coli isolates of broiler origin
Journal of Antimicrobial Chemotherapy, Volume 74, Issue 3, March 2019, Pages 557–560, https://doi.org/10.1093/jac/dky484
Limited contribution of non-intensive chicken farming to ESBL-producing Escherichia coli colonization in humans in Vietnam: an epidemiological and genomic analysis
Journal of Antimicrobial Chemotherapy, Volume 74, Issue 3, March 2019, Pages 561–570, https://doi.org/10.1093/jac/dky506
Characterization of mutations in Escherichia coli PBP2 leading to increased carbapenem MICs
Journal of Antimicrobial Chemotherapy, Volume 74, Issue 3, March 2019, Pages 571–576, https://doi.org/10.1093/jac/dky476
Emergence and rapid global dissemination of CTX-M-15-associated Klebsiella pneumoniae strain ST307
Journal of Antimicrobial Chemotherapy, Volume 74, Issue 3, March 2019, Pages 577–581, https://doi.org/10.1093/jac/dky492
Octapeptin C4 and polymyxin resistance occur via distinct pathways in an epidemic XDR Klebsiella pneumoniae ST258 isolate
Journal of Antimicrobial Chemotherapy, Volume 74, Issue 3, March 2019, Pages 582–593, https://doi.org/10.1093/jac/dky458
Klebsiella pneumoniae causing urinary tract infections in companion animals and humans: population structure, antimicrobial resistance and virulence genes
Journal of Antimicrobial Chemotherapy, Volume 74, Issue 3, March 2019, Pages 594–602, https://doi.org/10.1093/jac/dky499
A novel cfr-carrying Tn7 transposon derivative characterized in Morganella morganii of swine origin in China
Journal of Antimicrobial Chemotherapy, Volume 74, Issue 3, March 2019, Pages 603–606, https://doi.org/10.1093/jac/dky494
The HIV-1 reverse transcriptase E138A natural polymorphism decreases the genetic barrier to resistance to etravirine in vitro
Journal of Antimicrobial Chemotherapy, Volume 74, Issue 3, March 2019, Pages 607–613, https://doi.org/10.1093/jac/dky479
Rare occurrence of doravirine resistance-associated mutations in HIV-1-infected treatment-naive patients
Journal of Antimicrobial Chemotherapy, Volume 74, Issue 3, March 2019, Pages 614–617, https://doi.org/10.1093/jac/dky464
Challenging SNP impact on caspofungin resistance by full-length FKS1 allele replacement in Candida lusitaniae
Journal of Antimicrobial Chemotherapy, Volume 74, Issue 3, March 2019, Pages 618–624, https://doi.org/10.1093/jac/dky475
Evaluation of the ability of linezolid and tedizolid to eradicate intraosteoblastic and biofilm-embedded Staphylococcus aureus in the bone and joint infection setting
Journal of Antimicrobial Chemotherapy, Volume 74, Issue 3, March 2019, Pages 625–632, https://doi.org/10.1093/jac/dky473
Performance of ceftazidime/avibactam susceptibility testing methods against clinically relevant Gram-negative organisms
Journal of Antimicrobial Chemotherapy, Volume 74, Issue 3, March 2019, Pages 633–638, https://doi.org/10.1093/jac/dky483
Evaluation of temocillin for phenotypic carbapenemase screening of Escherichia coli and Salmonella enterica isolates in relation to the presence of genes encoding ESBLs and carbapenemase production
Journal of Antimicrobial Chemotherapy, Volume 74, Issue 3, March 2019, Pages 639–644, https://doi.org/10.1093/jac/dky493
Antimicrobial-resistant pathogens in Canadian ICUs: results of the CANWARD 2007 to 2016 study
Journal of Antimicrobial Chemotherapy, Volume 74, Issue 3, March 2019, Pages 645–653, https://doi.org/10.1093/jac/dky477
Combination treatment with the cap-dependent endonuclease inhibitor baloxavir marboxil and a neuraminidase inhibitor in a mouse model of influenza A virus infection
Journal of Antimicrobial Chemotherapy, Volume 74, Issue 3, March 2019, Pages 654–662, https://doi.org/10.1093/jac/dky462
In vivo evaluation of the antifungal activity of sertraline against Aspergillus fumigatus
Journal of Antimicrobial Chemotherapy, Volume 74, Issue 3, March 2019, Pages 663–666, https://doi.org/10.1093/jac/dky455
Pharmacokinetic evaluation of linezolid administered intravenously in obese patients with pneumonia
Journal of Antimicrobial Chemotherapy, Volume 74, Issue 3, March 2019, Pages 667–674, https://doi.org/10.1093/jac/dky500
Cerebrospinal fluid pharmacokinetics of ceftaroline in neurosurgical patients with an external ventricular drain
Journal of Antimicrobial Chemotherapy, Volume 74, Issue 3, March 2019, Pages 675–681, https://doi.org/10.1093/jac/dky489
Ciprofloxacin in critically ill subjects: considering hepatic function, age and sex to choose the optimal dose
Journal of Antimicrobial Chemotherapy, Volume 74, Issue 3, March 2019, Pages 682–690, https://doi.org/10.1093/jac/dky485
Population pharmacokinetics of ribavirin in lung transplant recipients and examination of current and alternative dosing regimens
Journal of Antimicrobial Chemotherapy, Volume 74, Issue 3, March 2019, Pages 691–698, https://doi.org/10.1093/jac/dky466
Pharmacogenetics and pharmacokinetics of CNS penetration of efavirenz and its metabolites
Journal of Antimicrobial Chemotherapy, Volume 74, Issue 3, March 2019, Pages 699–709, https://doi.org/10.1093/jac/dky481
Assessment of drug interaction potential between the HCV direct-acting antiviral agents elbasvir/grazoprevir and the HIV integrase inhibitors raltegravir and dolutegravir
Journal of Antimicrobial Chemotherapy, Volume 74, Issue 3, March 2019, Pages 710–717, https://doi.org/10.1093/jac/dky465
Impact of the mutational load on the virological response to a first-line rilpivirine-based regimen
Journal of Antimicrobial Chemotherapy, Volume 74, Issue 3, March 2019, Pages 718–721, https://doi.org/10.1093/jac/dky495
Pre-treatment drug resistance and HIV-1 subtypes in infants from Argentina with and without exposure to antiretroviral drugs for prevention of mother-to-child transmission
Journal of Antimicrobial Chemotherapy, Volume 74, Issue 3, March 2019, Pages 722–730, https://doi.org/10.1093/jac/dky486
Improvement in insulin sensitivity and serum leptin concentration after the switch from a ritonavir-boosted PI to raltegravir or dolutegravir in non-diabetic HIV-infected patients
Journal of Antimicrobial Chemotherapy, Volume 74, Issue 3, March 2019, Pages 731–738, https://doi.org/10.1093/jac/dky507
Dolutegravir and lamivudine maintenance therapy in HIV-1 virologically suppressed patients: results of the ANRS 167 trial (LAMIDOL)
Journal of Antimicrobial Chemotherapy, Volume 74, Issue 3, March 2019, Pages 739–745, https://doi.org/10.1093/jac/dky467
Virological outcomes of boosted protease inhibitor-based first-line ART in subjects harbouring thymidine analogue-associated mutations as the sole form of transmitted drug resistance
Journal of Antimicrobial Chemotherapy, Volume 74, Issue 3, March 2019, Pages 746–753, https://doi.org/10.1093/jac/dky468
Integrase strand transfer inhibitors and neuropsychiatric adverse events in a large prospective cohort
Journal of Antimicrobial Chemotherapy, Volume 74, Issue 3, March 2019, Pages 754–760, https://doi.org/10.1093/jac/dky497
Variability and exposure–response relationships of isavuconazole plasma concentrations in the Phase 3 SECURE trial of patients with invasive mould diseases
Journal of Antimicrobial Chemotherapy, Volume 74, Issue 3, March 2019, Pages 761–767, https://doi.org/10.1093/jac/dky463
Tolerability of long-term fluconazole therapy
Journal of Antimicrobial Chemotherapy, Volume 74, Issue 3, March 2019, Pages 768–771, https://doi.org/10.1093/jac/dky501
Role of MIC levels of resistance to clarithromycin and metronidazole in Helicobacter pylori eradication
Journal of Antimicrobial Chemotherapy, Volume 74, Issue 3, March 2019, Pages 772–774, https://doi.org/10.1093/jac/dky469
Antibiotic resistance of Enterobacteriaceae causing urinary tract infections in elderly patients living in the community and in the nursing home: a retrospective observational study
Journal of Antimicrobial Chemotherapy, Volume 74, Issue 3, March 2019, Pages 775–781, https://doi.org/10.1093/jac/dky488
Long-term impact of oral vancomycin, ciprofloxacin and metronidazole on the gut microbiota in healthy humans
Journal of Antimicrobial Chemotherapy, Volume 74, Issue 3, March 2019, Pages 782–786, https://doi.org/10.1093/jac/dky471
Intravenous catheter-related adverse events exceed drug-related adverse events in outpatient parenteral antimicrobial therapy
Journal of Antimicrobial Chemotherapy, Volume 74, Issue 3, March 2019, Pages 787–790, https://doi.org/10.1093/jac/dky474
Antibiotic prescribing for the older adult: beliefs and practices in primary care
Journal of Antimicrobial Chemotherapy, Volume 74, Issue 3, March 2019, Pages 791–797, https://doi.org/10.1093/jac/dky504
Quantitative and qualitative analysis of antimicrobial usage at farm and flock level on 181 broiler farms in nine European countries
Journal of Antimicrobial Chemotherapy, Volume 74, Issue 3, March 2019, Pages 798–806, https://doi.org/10.1093/jac/dky498
Quantitative and qualitative analysis of antimicrobial usage patterns in 180 selected farrow-to-finish pig farms from nine European countries based on single batch and purchase data
Journal of Antimicrobial Chemotherapy, Volume 74, Issue 3, March 2019, Pages 807–816, https://doi.org/10.1093/jac/dky503
Research letters
Detection in Italy of a porcine Enterococcus faecium isolate carrying the novel phenicol-oxazolidinone-tetracycline resistance gene poxtA
Journal of Antimicrobial Chemotherapy, Volume 74, Issue 3, March 2019, Pages 817–818, https://doi.org/10.1093/jac/dky505
Novel pseudo-staphylococcal cassette chromosome mec element (φSCCmecT55) in MRSA ST9
Journal of Antimicrobial Chemotherapy, Volume 74, Issue 3, March 2019, Pages 819–820, https://doi.org/10.1093/jac/dky457
AbGRI1-5, a novel AbGRI1 variant in an Acinetobacter baumannii GC2 isolate from Adelaide, Australia
Journal of Antimicrobial Chemotherapy, Volume 74, Issue 3, March 2019, Pages 821–823, https://doi.org/10.1093/jac/dky459
A novel IncQ plasmid carrying gene blaCTX-M-3 in Pseudomonas aeruginosa
Journal of Antimicrobial Chemotherapy, Volume 74, Issue 3, March 2019, Pages 823–825, https://doi.org/10.1093/jac/dky454
Salmonella harbouring the mcr-1 gene isolated from food in China between 2012 and 2016
Journal of Antimicrobial Chemotherapy, Volume 74, Issue 3, March 2019, Pages 826–828, https://doi.org/10.1093/jac/dky496
Ciprofloxacin penetration into infected hepatic cysts in autosomal dominant polycystic kidney disease: a case report
Journal of Antimicrobial Chemotherapy, Volume 74, Issue 3, March 2019, Pages 829–830, https://doi.org/10.1093/jac/dky456
Letters to the Editor
Comment on: CG258 Klebsiella pneumoniae isolates without β-lactam resistance at the onset of the carbapenem-resistant Enterobacteriaceae epidemic in New York City
Journal of Antimicrobial Chemotherapy, Volume 74, Issue 3, March 2019, Pages 831–833, https://doi.org/10.1093/jac/dky472
CG258 Klebsiella pneumoniae isolates without β-lactam resistance at the onset of the carbapenem-resistant Enterobacteriaceae epidemic in New York City—author response
Journal of Antimicrobial Chemotherapy, Volume 74, Issue 3, March 2019, Page 833, https://doi.org/10.1093/jac/dky480
Comment on: The potential use of rifabutin for treatment of patients diagnosed with rifampicin-resistant tuberculosis
Journal of Antimicrobial Chemotherapy, Volume 74, Issue 3, March 2019, Page 834, https://doi.org/10.1093/jac/dky490
